Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)
Encontrada(s) 1 página(s)
CORA.Repositori de Dades de Recerca
doi:10.34810/data405
Dataset. 2016
CANCER BIOMARKERS DATABASE
- Tamborero Noguera, David
- Rubio Pérez, Carlota
- Déu Pons, Jordi
- Schroeder, Michael Philipp, 1986-
- Vivancos Prellezo, Ana
- Rovira Guerín, Ana
- Tusquets, Ignasi
- Albanell Mestres, Joan
- Rodon, Jordi
- Tabernero Cartula, Josep
- Dienstmann, Rodrigo
- González-Pérez, Abel
- López Bigas, Núria
The cancer bioMarkers database is curated and maintained by several clinical and scientific experts in the field of precision oncology supported by the European Union’s Horizon 2020 funding. This database is currently being integrated with knowledge databases of other institutions in a collaborative effort of the Global Alliance for Genomics and Health.
Proyecto: //
CORA.Repositori de Dades de Recerca
doi:10.34810/data406
Dataset. 2023
ONCOPAD
- Tamborero Noguera, David
- López Bigas, Núria
- González-Pérez, Abel
- Rubio Pérez, Carlota
- Déu Pons, Jordi
A tool aimed at the rational design of cancer gene panels. It estimates the cost-effectiveness of the designed panel on a cohort of tumors and provides reports on the importance of individual mutations for tumorigenesis or therapy.
Proyecto: //
CORA.Repositori de Dades de Recerca
doi:10.34810/data416
Dataset. 2023
ONCODRIVEROLE
- Schroeder, Michael Philipp, 1986-
- Rubio Pérez, Carlota
- Tamborero Noguera, David
- González-Pérez, Abel
- López Bigas, Núria
Machine-learning based approach to classify cancer driver genes into to Activating or Loss of Function roles for cancer gene development.
Proyecto: //
CORA.Repositori de Dades de Recerca
doi:10.34810/data429
Dataset. 2023
INTOGEN - CANCER DRIVERS DATABASE (2014)
- Rubio Pérez, Carlota
- Tamborero Noguera, David
- Schroeder, Michael Philipp, 1986-
- Antolín Hernández, Albert, 1984-
- Déu Pons, Jordi
- Pérez Llamas, Christian, 1976-
- Mestres i López, Jordi
- González-Pérez, Abel
- López Bigas, Núria
This database contains information on the genes identified as drivers in Rubio-Perez and Tamborero et al. (2015). It contains information on driver identification at mutational, CNA and gene fusion level. Additional ancillary information about the role and major clonality of drivers is also included. A table is also provided with the list of datasets used for mutational driver identification.
Proyecto: //
CORA.Repositori de Dades de Recerca
doi:10.34810/data432
Dataset. 2022
ONCODRIVEMUT
- Tamborero Noguera, David
- Rubio Pérez, Carlota
- Déu Pons, Jordi
- Schroeder, Michael Philipp, 1986-
- Vivancos Prellezo, Ana
- Rovira Guerín, Ana
- Tusquets, Ignasi
- Albanell Mestres, Joan
- Rodon, Jordi
- Tabernero Cartula, Josep
- Dienstman, Rodrigo
- González-Pérez, Abel
- López Bigas, Núria
Bioinformatics method to identify individual driver mutations.
Proyecto: //
CORA.Repositori de Dades de Recerca
doi:10.34810/data433
Dataset. 2022
INTOGEN - CATALOG OF DRIVER MUTATIONS
- Tamborero Noguera, David
- Rubio Pérez, Carlota
- Déu Pons, Jordi
- Schroeder, Michael Philipp, 1986-
- Vivancos Prellezo, Ana
- Rovira Guerín, Ana
- Tusquets, Ignasi
- Albanell Mestres, Joan
- Tabernero Cartula, Josep
- Dienstman, Rodrigo
- González-Pérez, Abel
- López Bigas, Núria
This database contains the results of the driver analysis performed by the Cancer Genome Interpreter across 6,792 exomes of a pan-cancer cohort of 28 tumor types. Validated oncogenic mutations are identified according to the state-of-the-art clinical and experimental data, whereas the effect of the mutations of unknown significance is predicted by the OncodriveMUT method.
Proyecto: //
CORA.Repositori de Dades de Recerca
doi:10.34810/data436
Dataset. 2022
TCGI PRESCRIPTION
- Tamborero Noguera, David
- Rubio Pérez, Carlota
- Déu Pons, Jordi
- Schroeder, Michael Philipp, 1986-
- Vivancos Prellezo, Ana
- Rovira Guerín, Ana
- Tusquets, Ignasi
- Albanell Mestres, Joan
- Rodon, Jordi
- Tabernero Cartula, Josep
- Dienstman, Rodrigo
- González-Pérez, Abel
- López Bigas, Núria
CGI drug prescription assigns targeted drugs to a tumor, based on its genomic alterations, according different levels of evidence (from pre-clinical assays to clinical guidelines).
Proyecto: //
Buscador avanzado